JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.65B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.08B |
| 3 |
Microsoft
MSFT
|
+$2.05B |
| 4 |
Vanguard Total International Bond ETF
BNDX
|
+$1.64B |
| 5 |
Micron Technology
MU
|
+$1.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$2.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.11B |
| 3 |
Progressive
PGR
|
+$1.64B |
| 4 |
Salesforce
CRM
|
+$1.54B |
| 5 |
Adobe
ADBE
|
+$1.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.15% |
| 2 | Technology | 24.03% |
| 3 | Healthcare | 9.24% |
| 4 | Consumer Discretionary | 8.79% |
| 5 | Financials | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5301
Nuvectis Pharma
NVCT
$695M
| $93.4K | ﹤0.01% |
14,753
+9,588
| +186% | +$65.2K |
2023 Q2
4 quarters
|
|
5302
Innovator US Equity Power Buffer ETF August
PAUG
$1.05B
| $93.4K | ﹤0.01% |
2,557
-58,633
| -96% | -$2.09M |
2023 Q2
4 quarters
|
|
|
SNBR
5303
DELISTED
Sleep Number
SNBR
| $93.3K | ﹤0.01% |
9,747
-32
| -0.3% | -$438 |
2014 Q3
39 quarters
|
|
5304
CALL
AB InBev
BUD
$145B
| $93K | ﹤0.01% |
+1,600
| New | +$98K |
2024 Q2
0 quarters
|
|
5305
Frontier Group Holdings
ULCC
$1.42B
| $92.9K | ﹤0.01% |
18,851
+2,970
| +19% | +$17.8K |
2021 Q2
12 quarters
|
|
|
AOMR
5306
Angel Oak Mortgage REIT
AOMR
$169M
| $92.5K | ﹤0.01% |
7,059
-18,020
| -72% | -$210K |
2021 Q3
11 quarters
|
|
|
ZH
5307
Zhihu
ZH
$290M
| $92.5K | ﹤0.01% |
+33,872
| New | +$124K |
2024 Q2
0 quarters
|
|
5308
Orchestra BioMed
OBIO
$374M
| $92.3K | ﹤0.01% |
11,320
+5,124
| +83% | +$29.7K |
2023 Q2
4 quarters
|
|
5309
PUT
iShares Gold Trust
IAU
$62B
| $92.3K | ﹤0.01% |
2,100
-3,700
| -64% | -$164K |
2024 Q1
1 quarter
|
|
5310
EVI Industries
EVI
$258M
| $92.1K | ﹤0.01% |
4,867
-4,103
| -46% | -$85.3K |
2023 Q2
4 quarters
|
|
5311
Fidelity D&D Bancorp
FDBC
$318M
| $92.1K | ﹤0.01% |
2,102
-5,432
| -72% | -$250K |
2018 Q2
24 quarters
|
|
|
STEW
5312
SRH Total Return Fund
STEW
$1.69B
| $92K | ﹤0.01% |
6,320
-1,600
| -20% | -$23.2K |
2022 Q4
6 quarters
|
|
|
AFCG
5313
AFC Gamma
AFCG
$77.1M
| $91.9K | ﹤0.01% |
11,009
-11,807
| -52% | -$97.2K |
2021 Q2
12 quarters
|
|
5314
Pulse Biosciences
PLSE
$3.55B
| $91.5K | ﹤0.01% |
8,180
-1,053
| -11% | -$9.92K |
2017 Q4
26 quarters
|
|
5315
Zevra Therapeutics
ZVRA
$600M
| $91.5K | ﹤0.01% |
18,665
+3,604
| +24% | +$17.1K |
2021 Q2
12 quarters
|
|
5316
HighPeak Energy
HPK
$994M
| $91.4K | ﹤0.01% |
6,503
-6,595
| -50% | -$97.3K |
2021 Q1
13 quarters
|
|
5317
Inovio Pharmaceuticals
INO
$123M
| $91.3K | ﹤0.01% |
11,296
+10,823
| +2,288% | +$114K |
2014 Q3
39 quarters
|
|
5318
Inspired Entertainment
INSE
$97M
| $91.2K | ﹤0.01% |
9,969
+1,184
| +13% | +$10.8K |
2019 Q2
20 quarters
|
|
5319
Clarus
CLAR
$131M
| $91K | ﹤0.01% |
13,525
+869
| +7% | +$5.73K |
2017 Q1
29 quarters
|
|
|
SKYT
5320
DELISTED
SkyWater Technology
SKYT
| $90.9K | ﹤0.01% |
11,881
+4,150
| +54% | +$36K |
2021 Q2
12 quarters
|
|
5321
Akebia Therapeutics
AKBA
$236M
| $90.7K | ﹤0.01% |
88,884
+88,653
| +38,378% | +$110K |
2017 Q4
26 quarters
|
|
|
HTZWW
5322
Hertz Global Holdings Warrants
HTZWW
$76.8M
| – | – |
0
| – | – |
2021 Q4
10 quarters
|
|
|
MRX
5323
Marex Group Limited Ordinary Shares
MRX
$5.21B
| $90.3K | ﹤0.01% |
+4,516
| New | +$88.8K |
2024 Q2
0 quarters
|
|
5324
Fidelity Enhanced Large Cap Core ETF
FELC
$8.67B
| $90.3K | ﹤0.01% |
2,950
-11,374
| -79% | -$334K |
2023 Q4
2 quarters
|
|
5325
Forrester Research
FORR
$218M
| $90.2K | ﹤0.01% |
5,280
-46,714
| -90% | -$858K |
2016 Q2
32 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2024 Portfolio in Review
As of Q2 2024, JP Morgan Chase held 7,917 positions worth $1.22T, up 3% from $1.18T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q2 2024 filing shows 549 new, 2,506 increased, 3,286 reduced and 578 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M. The largest sale was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $2.4B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2024 buy was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M.
- JP Morgan Chase added most to Apple in Q2 2024, an estimated $4.65B increase.
- JP Morgan Chase's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.11B.
- JP Morgan Chase fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2024, selling an estimated $2.4B.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.22T portfolio in Q2 2024.
- JP Morgan Chase opened 549 new positions and closed 578 in Q2 2024.
- JP Morgan Chase's portfolio value rose 3% quarter-over-quarter to $1.22T.
Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.